2013 CPHI Worldwide successfully held at Messe Frankfurt Germany, 22 - 24 October. Here is the JK's News Releases published on Show Daily:

JKsweet: A Solution for a Healthy Life

This year JK Sucralose Inc. brings granular and micronized sucralose products in Pharmaceutical Grade to the global Pharma clients, adding the logic and healthy solution without compromise on sugar taste in pharmaceuticals. Sucralose is the latest high intensive sweetener with great performance stability and safety, which is considered as the most preferred sweetener widely used in pharmaceutical applications.

JK Sucralose Inc., located in Yancheng, Jiangsu Province of China, has designed long-term capacity of 4000 tons. The company focuses on producing only one product--"JK Sweet® " sucralose, which is supplied to more than 90 countries and regions and applied in various industries. JK Sucralose has established a marketing and sales network for its global strategy, with marketing headquarters set in Beijing and sales branches in US, Europe, Japan and India.
 
The company is in full compliance with global standards including FCCVII, USP34 NF35, EP 7.2, EC231/2012(2008/60/EC), GB25531, Japanese Standards, and etc. JK is dedicated in providing differentiated and diversified solutions to pharmaceutical customers. 

According to the new EU regulation 432-2012, starting in December 2012, a health claim can be done (only in Europe) if more than 30% sugar in the product is replaced with sucralose. It is expected that sucralose will be more popular among pharma processing companies, and will be even more widely used in syrup, tablet, capsule, oral solution and so on.
 
Guided by the idea of “sustainable development”, JK has shouldered its own corporate social responsibility in aspects of environment protection, social benefits and social security.